REGISTERED NUMBER: |
Unaudited Financial Statements |
for the Period 1 October 2022 to 31 March 2024 |
for |
S2S Health Limited |
REGISTERED NUMBER: |
Unaudited Financial Statements |
for the Period 1 October 2022 to 31 March 2024 |
for |
S2S Health Limited |
S2S Health Limited (Registered number: 08655843) |
Contents of the Financial Statements |
for the Period 1 October 2022 to 31 March 2024 |
Page |
Company Information | 1 |
Balance Sheet | 2 |
Notes to the Financial Statements | 3 |
S2S Health Limited |
Company Information |
for the Period 1 October 2022 to 31 March 2024 |
DIRECTORS: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
Bank Chambers |
31 The Square |
Cumnock |
Ayrshire |
KA18 1AT |
S2S Health Limited (Registered number: 08655843) |
Balance Sheet |
31 March 2024 |
31.3.24 | 30.9.22 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors | 4 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 5 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital |
Retained earnings |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
The financial statements were approved by the Board of Directors and authorised for issue on |
S2S Health Limited (Registered number: 08655843) |
Notes to the Financial Statements |
for the Period 1 October 2022 to 31 March 2024 |
1. | STATUTORY INFORMATION |
S2S Health Limited is a |
The presentation currency of the financial statements is the Pound Sterling (£). |
ACCOUNTING PERIOD |
S2S Health Limited changed it's accounting reference date to 31 March and accordingly the accounts presented cover the period from 1 October 2022 to 31 March 2024. |
COMPARATIVE AMOUNTS |
Comparative amounts presented refer to the year ended 30 September 2022. |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
Taxation |
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
3. | EMPLOYEES AND DIRECTORS |
The average number of employees during the period was |
4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.24 | 30.9.22 |
£ | £ |
Other debtors |
S2S Health Limited (Registered number: 08655843) |
Notes to the Financial Statements - continued |
for the Period 1 October 2022 to 31 March 2024 |
5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.3.24 | 30.9.22 |
£ | £ |
Trade creditors |
Taxation and social security |
Other creditors |
6. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
LOANS FROM DIRECTORS |
All Directors loans are interest free and repayable on demand |
31.3.24 | 30.09.22 |
Dr S S Sapre Loan account | £ | £ |
At 1 October 2022 | 91,597 | 91,957 |
Maximum amount due | 91,597 | 91,597 |
At 31 March 2024 | 90,808 | 91,597 |
Mrs S Sapre |
At 1 October 2022 | 7,914 | 7,914 |
Maximum amount due | 7,914 | 7,914 |
At 31 March 2024 | 7,302 | 7,914 |
Dr J Krecichwost |
At 1 October 2022 | 2,560 | 2,560 |
Maximum amount due | 2,560 | 2,560 |
At 31 March 2024 | 2,560 | 2,560 |
Dr B Sapre |
At 1 October 2022 | 4,762 | 4,762 |
Maximum amount due | 7,384 | 4,762 |
At 31 March 2024 | 7,384 | 4,762 |
S2S Health Limited (Registered number: 08655843) |
Notes to the Financial Statements - continued |
for the Period 1 October 2022 to 31 March 2024 |
7. | RELATED PARTY DISCLOSURES |
Dr S S SAPRE PARTNERSHIP |
Dr S Sapre, Mrs S Sapre, Dr J Krecichwost and Dr U Farooq are partners in Dr S&S Sapre Partnership |
and Directors in S2S Health Limited. |
The following transactions took place between S2S Health Limited and Dr S&S Sapre Partnership: |
31.3.24 |
£ |
Due to S2S Health Limited at 1 October 2022 | 78,776 |
Management charge to S2S Health Limited | (516,979 | ) |
Payments made to or for partnership | 295,618 |
Due (by) S2S Health Limited at 31 March 2024 | (142,585 | ) |
SEABRIGHT ENTERPRISES LIMITED |
Dr S S Sapre and Mrs S Sapre are directors and shareholders of Seabright Enterprises Limited and directors and shareholders of S2S Health Limited.. |
The following transactions took place between S2S Health Limited and Seabright Enterprises Limited |
31.3.2024 |
£ |
Due to S2S Health Limited at 1 October 2022 and 31 March 2024 | 1,335,356 |
8. | ULTIMATE CONTROLLING PARTY |
The controlling party is Dr S S Sapre. |